Fumiya Baba

Toyohashi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Adaptive Palliative Stereotactic Body Radiotherapy for a Large Cervical Lymph Node Metastasis in a Near-Centenarian Patient: A Case Report.

Adaptive Palliative Stereotactic Body Radiotherapy for a Large Cervical Lymph Node Metastasis in a Near-Centenarian Patient: A Case Report.

Journal: Cureus

Published: June 17, 2026

Initial Experience With Stereotactic Radiosurgery for Refractory Trigeminal Neuralgia Using the OXRAY System.

Initial Experience With Stereotactic Radiosurgery for Refractory Trigeminal Neuralgia Using the OXRAY System.

Journal: Cureus

Published: May 10, 2026

Long-term survival outcomes and quality of life of image-guided proton therapy for operable stage I non-small cell lung cancer: A phase 2 study.

Long-term survival outcomes and quality of life of image-guided proton therapy for operable stage I non-small cell lung cancer: A phase 2 study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 12, 2024

Dose Prescription to Isodose Lines in Static Multi-Beam Stereotactic Body Radiotherapy for Lung Tumors: Which Line Is Optimal?

Dose Prescription to Isodose Lines in Static Multi-Beam Stereotactic Body Radiotherapy for Lung Tumors: Which Line Is Optimal?

Journal: The Kurume medical journal

Published: January 17, 2024

Clinical Outcomes of Intraoperative Radiotherapy, Postoperative Radiotherapy, and Definitive Radiotherapy for Non-metastatic Pancreatic Cancer.

Clinical Outcomes of Intraoperative Radiotherapy, Postoperative Radiotherapy, and Definitive Radiotherapy for Non-metastatic Pancreatic Cancer.

Journal: The Kurume medical journal

Published: November 30, 2022

Daily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: study protocol for a multicenter open-label randomized phase II trial.

Daily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: study protocol for a multicenter open-label randomized phase II trial.

Journal: BMC cancer

Published: October 25, 2022

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer.

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer.

Journal: Radiation oncology (London, England)

Published: August 22, 2018

Definitive radiotherapy for hilar and/or mediastinal lymph node metastases after stereotactic body radiotherapy or surgery for stage I non-small cell lung cancer: 5-year results.

Definitive radiotherapy for hilar and/or mediastinal lymph node metastases after stereotactic body radiotherapy or surgery for stage I non-small cell lung cancer: 5-year results.

Journal: Japanese journal of radiology

Published: May 11, 2018

Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study.

Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study.

Journal: Radiation oncology (London, England)

Published: June 27, 2017

Definitive Radiotherapy Following Induction Chemotherapy for Hypopharyngeal Cancer: Selecting Candidates for Organ-Preserving Treatment Based on the Response to Induction Chemotherapy.

Definitive Radiotherapy Following Induction Chemotherapy for Hypopharyngeal Cancer: Selecting Candidates for Organ-Preserving Treatment Based on the Response to Induction Chemotherapy.

Journal: The Kurume medical journal

Published: March 04, 2016

Effects of audio coaching and visual feedback on the stability of respiration during radiotherapy.

Effects of audio coaching and visual feedback on the stability of respiration during radiotherapy.

Journal: Japanese journal of radiology

Published: December 15, 2015

The Fate of Residual Tumor Masses That Persist After Stereotactic Body Radiotherapy for Solitary Lung Nodules: Will They Recur?

The Fate of Residual Tumor Masses That Persist After Stereotactic Body Radiotherapy for Solitary Lung Nodules: Will They Recur?

Journal: Clinical lung cancer

Published: September 28, 2015

Showing 1-12 of 20

Last Updated: 09/26/2026